R
Relmada Therapeutics D
D
RLMD
0.57710
USD
-0.02
(-3.07%)
مغلق
حجم التداول
632
الربح لكل سهم
-3
العائد الربحي
-
P/E
-0
حجم السوق
19,154,885
العنوان: Relmada Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous systemdiseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.